Parameters of oxidative stress and echocardiographic indexes in patients on dialysis therapy

REFERENCES

• Locatelli F, Marcelli D, Conte F, Cardiovascular disease in chronic renal failure: The challenge continues. Nephrol Dial Transplant. 2000;15(Suppl. 5):S69–S80.
   PubMedGoogle Scholar
• Levey AS, Beto JA, Coronado BE, Controling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis. 1998;32:853–906.
   PubMed Web of Science ®Google Scholar
• Sit D, Kadiroglu AK, Kayabasi H, The evaluation incidence and risk factors of mortality among patients with end stage renal disease in Southeast Turkey. Ren Fail. 2008; 30(1):37–44.
   Web of Science ®Google Scholar
• Zoccali C. Cardiovascular risk in uraemic patients – is it fully explained by classical risk factors? Nephrol Dial Transplant. 2000;15:454–457.
   PubMed Web of Science ®Google Scholar
• Ronco C, La Greca G. Vitamin E bonded membrane, a further step in dialysis optizimation. Contrib Nephrol. 1999;127:1–31.
   Google Scholar
• Sies H. Oxidants and antioxidants. Exp Physiol. 1997;82:291–295.
   PubMed Web of Science ®Google Scholar
• Boaz M, Matas Z, Biro A, Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int. 1999;56:1078–1083.
   PubMed Web of Science ®Google Scholar
• Harma M, Harma M, Kocyigit A, Erel O. Increased DNA damage in patients with complete hydatiform mole. J Mutat Res. 2005;583:49–54.
   PubMed Web of Science ®Google Scholar
• Conti M, Morand PC, Levillain P, Lemonnier A. Improved fluorimetric determination of malondialdehyde. Clin Chem. 1991;37(7):1273–1275.
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymatic function for erytrocuprein (hemocuprein). J Biol Chem. 1969;244:6049–6055.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentina WN. Glutathione peroxi-dase. J Lab Clin Med. 1967;70:158.
   PubMed Web of Science ®Google Scholar
• Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003;16(2):101–105.
   Google Scholar
• Drueke T, Witko-Sarsat V, Massy Z, Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation. 2002;106:2212–2217.
   PubMed Web of Science ®Google Scholar
• Tsirpanlis G. Cellular senescence, cardiovascular risk, and CKD: A review of established and hypothetical interconnections. Am J Kidney Dis. 2008;51(1):131–144.
   Google Scholar
• Matteucci E, Cupisti A, Caprioli R, Erythrocyte transmembrane electron transfer in hemodialysis patients. Nutr Metab Cardiovasc Dis. 2007;17(4):288–293.
   Google Scholar
• Avissar N, Ornt BA, Yagil Y, Horowitz S. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol. 1994;266:367–375.
   PubMed Web of Science ®Google Scholar
• Çeliker H, Elkıran B, İlhan N, Günal Aİ, Doğukan A. The effects of hemodialysis and peritoneal dialysis on oxidative stres parameters. Official J Turk Soc Nephrol. 2001;10(2):88–92.
   Google Scholar
• Köse K, Doğan P, Gündüz S, Düşünsel R, Utaş C. Oxidative stress in hemodialysis patients and long term effects of dialyzer reuse practice. Clin Biochem. 1997;30:601–606.
   Google Scholar
• Wu CC, Chen JS, Wu WM, Myeloperoxidase serves as a marker of oxidative stress during single hemodialysis session using two different biocompatible dialysis membranes. Nephrol Dial Transplant. 2005;20(6):1134–1139.
   Google Scholar
• Ilgen C, Bulucu F, Yamanel L, The effect of different dialyzer membranes on the oxidative burst status of polymorphonuclear leukocytes in hemodialysis patients. Official J Turk Soc Nephrol. 2007;16(2):63–67.
   Google Scholar
• Johnson DW, Armstrong K, Campbell SB, Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton). 2007;12(4):391–398.
   PubMedGoogle Scholar
• Cristol JP, Bose JY, Badiou S, Erythropoietin and oxidative stress in hemodialysis. Benefical effects of vitamin E supplementation. Nephrol Dial Transplant. 1997;12:2312–2317.
   PubMed Web of Science ®Google Scholar
• Rysz J, Stolarek RA, Pedzik A, Increased exhaled H2O2 and impaired lung function in patients undergoing bioincompatible hemodialysis. Int J Artif Organs. 2007;30(10):879–888.
   Google Scholar
• Biasioli S, Schiavon R, Petrosino L, Free radicals and oxidative stress challenge dialysis patients: Effects of two different membranes. ASAIO J. 1997;43(5):M766–M772.
   Google Scholar
• Al-Hashimi AF, Mohammed FH, Al-Khazragi AS. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis. Saudi Med J. 2004;25(9):1186–1192.
   Google Scholar
• Yano S. Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease. Clin Calcium. 2007;17(12):1870–1878.
   Google Scholar
• Pawlak K, Pawlak D, Mysliwiec M. Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure. Pol Arch Med Wewn. 2005;113(1):21–26.
   Google Scholar
• Yilmaz MI, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: Sources and consequences. Clin Nephrol. 2007;68(1):1–9.
   Google Scholar
• Scott B, Deman A, Peeters P, Cardiac troponin T and malondialdehyde modified plasma lipids in hemodialysis patients. Nephrol Dial Transplant. 2003;18(4):737–742.
   PubMedGoogle Scholar
• Ece A, Gürkan F, Kervancioğlu M, Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol. 2006;21(4): 545–552.
   Google Scholar
• Gugliucci A, Mehlhaff K, Kinugasa E, Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: Correlation with low molecular AGE adduct clearance. Clin Chim Acta. 2007;377(1–2):213–220.
   Google Scholar
• Liao Y Cooper RS, McGee DL, Mensah G, Ghali JK. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995;273:1592–1597.
   PubMed Web of Science ®Google Scholar